2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles (original) (raw)

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Zhihong Lai

Cancer Research, 2008

View PDFchevron_right

Azole-based inhibitors of AKT/PKB for the treatment of cancer

Qingping Zeng

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors

Keith Claiborne

Bioorganic & Medicinal Chemistry, 2006

View PDFchevron_right

Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors

Nestor Concha

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-f][1,6]naphthyridines with potent and balanced activity

Sachin Mittal

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

In search of AKT kinase inhibitors as anticancer agents: structure-based design, docking, and molecular dynamics studies of 2,4,6-trisubstituted pyridines

Alicia Hernández-Campos

Journal of Biomolecular Structure & Dynamics, 2017

View PDFchevron_right

IN SILICO STUDIES OF INDAZOLE PYRIDINE ANALOGS AS POTENT INHIBITORS OF AKT PROTEIN IN CANCER

Manoj Kumar

View PDFchevron_right

Design of Selective, ATP-Competitive Inhibitors of Akt

Shaughnessy Robinson, Shefali Kakar

Journal of Medicinal Chemistry, 2010

View PDFchevron_right

Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2

David Robert

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

AKT crystal structure and AKT-specific inhibitors

chandra kumar

Oncogene, 2005

View PDFchevron_right

Aminofurazans as potent inhibitors of AKT kinase

Nestor Concha

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors

Dengming Xiao

View PDFchevron_right

Optimal Classes of Chemotherapeutic Agents Sensitized by Specific Small-Molecule Inhibitors of Akt In Vitro and In Vivo

Vered Klinghofer

Neoplasia, 2005

View PDFchevron_right

A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity

Igor Vivanco

British Journal of Cancer

View PDFchevron_right

Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo

phong nguyen

Molecular Cancer Therapeutics, 2005

View PDFchevron_right

Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor

Shu-Yun Zhang

PloS one, 2014

View PDFchevron_right

The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity

Raymond Jones

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right

Identification and characterization of pleckstrin-homology-domain- dependent and isoenzyme-specific Akt inhibitors

xiaobing lu

View PDFchevron_right

Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors

George Hartman

Bioorganic & Medicinal Chemistry Letters, 2005

View PDFchevron_right

A comprehensive structure–activity analysis of protein kinase B-alpha (Akt1) inhibitors

Sudhir Kulkarni

Journal of Molecular Graphics & Modelling, 2010

View PDFchevron_right

2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics

Qingping Zeng

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

Octavian Olaru

International Journal of Oncology, 2015

View PDFchevron_right

Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor

Mahmoud A Al-Sha'er

Journal of Molecular Graphics & Modelling, 2018

View PDFchevron_right

Discovery and Optimization of a Series of 3-(3-Phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors

Susan Cornell-Kennon, Nivedita Namdev, Cathy Bull, S. Koerner, S. Eathiraj

Journal of Medicinal Chemistry, 2012

View PDFchevron_right